VTYX (Ventyx Biosciences) Short-Term Debt to Capital
Ventyx Biosciences (VTYX) automates the discovery of immune drugs by leveraging AI modeling and robotics to accelerate primary research. The market price trend on GURU.Markets, where the indicator stands at 0.00, visualizes the company's dynamics. Business development relies on a team of leading immunologists, who are attracted by an innovative environment and stock option programs to create breakthrough methods for combating inflammation.
Analytical breakdowns for Ventyx Biosciences
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Ventyx Biosciences|VTYX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Ventyx Biosciences, Inc.|VTYX - Aggregate Debt Obligations|Debts to Book Capitalization Ventyx Biosciences Inc.|VTYX - Long-Term Debt Volume|Company Short-Term Debt Ventyx Biosciences|Quick Liquidity ventyxbio.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Ventyx Bio
Assessing the operational strength of assets begins with an analysis of short-term liabilities. For Ventyx Biosciences (VTYX), which does not own its own factories and operates through contractors, flexible liquidity is critical. The trend of the short-term debt-to-equity ratio reflects the proportion of "fast" loans within the financing structure. Low values for this metric confirm business resilience and the absence of risks regarding sudden cash shortages.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV: Short-Term Debt to Equity Ratio|SEPN: Short-Term Debt to Equity|PVLA: Short-Term Debt to Capital|Current Liabilities to Capital savarapharma.com (SVRA)|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|Short-Term Debt to Capital Ratio ANAB (AnaptysBio Inc)|Short-Term Debt to Equity Ratio ATXS (Astria Pharma)|Short-Term Loans to Capital Ratio ENGN|RAPT Therapeutics - Short-Term Debt to Equity Ratio|Aerovate Therapeutics, Inc. (JBIO) - Current Liabilities to Capital|ACRS: Short-Term Debt to Equity Ratio|KYTX (Kyverna Therapeutics Inc.) - Short-Term Debt to Capital Ratio|TLSA (Tiziana Life Sciences PLC) - Short-Term Debt to Equity Ratio|Cabaletta Bio Inc - Ratio of Short-Term Indebtedness to Capital|THTX (Theratechnologies Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity AVTX|Short-Term Debt to Capital ELDN|Short-Term Debt to Capital Coefficient Agenus, Inc.|Short-Term Debt to Equity Climb Bio, Inc. CLYM|zurabio.com (ZURA) - Current Liabilities to Capital|ATYR - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Adagene ADAG|IMA: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Shattuck Labs|EQ (Equillium Inc) - Short-Term Debt to Capital|Connect Pharma (CNTB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital IMUX|ATRA - Current Liabilities to Capital|Short-Term Debt to Equity InflaRx IFRX|XFOR: Short-Term Debt to Capital Ratio|Adicet - Short-Term Debt to Capital|Celularity Inc. (CELU) - Short-Term Debt to Equity Ratio|INMB: Short-Term Debt to Capital|Current Liabilities to Capital barinthusbio.com (BRNS)|Short-Term Debt to Equity Kezar Life Sciences, Inc.|SAB Biotherapeutics Inc. (SABS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio AKTX (Akari Therapeutics plc)|Short-Term Debt to Equity ENLV (enlivex.com)|Q32 Bio - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio GOVX (geovax.com)|EDSA: Short-Term Debt to Equity Ratio|Current Liabilities to Capital iBio Inc|CARM (carismatx.com) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Ratio XTLB|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCW Biologics Inc - Current Liabilities to Equity|Short-Term Debt to Capital APVO|AIM (aimimmuno.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Short-Term Debt to Capital GRI Bio Corporation GRI|XRTX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital HIND (reshapelifesciences.com)|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Indaptus Therapeutics Inc|SCNI (Scinai) - Short-Term Debt to Capital|Short-Term Debt to Capital CalciMedica Corp|Short-Term Debt to Equity Ratio AFMD (Affimed)|ALLK (allakos.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital Coefficient IGM Biosciences Inc. (IGMS)|ITOS - Short-Term Debt to Equity|Ocean Biomedical Corp (OCEA) - Short-Term Debt to Equity Ratio|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com